EI

281.6

+0.86%↑

SAN

86

+0.73%↑

MRK1

119.4

+0.67%↑

SHL.DE

47.18

+0.66%↑

UCB

251.9

+2.07%↑

EI

281.6

+0.86%↑

SAN

86

+0.73%↑

MRK1

119.4

+0.67%↑

SHL.DE

47.18

+0.66%↑

UCB

251.9

+2.07%↑

EI

281.6

+0.86%↑

SAN

86

+0.73%↑

MRK1

119.4

+0.67%↑

SHL.DE

47.18

+0.66%↑

UCB

251.9

+2.07%↑

EI

281.6

+0.86%↑

SAN

86

+0.73%↑

MRK1

119.4

+0.67%↑

SHL.DE

47.18

+0.66%↑

UCB

251.9

+2.07%↑

EI

281.6

+0.86%↑

SAN

86

+0.73%↑

MRK1

119.4

+0.67%↑

SHL.DE

47.18

+0.66%↑

UCB

251.9

+2.07%↑

Search

BioMerieux

Aperta

SettoreSettore sanitario

116.2 0.43

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

115.5

Massimo

116.3

Metriche Chiave

By Trading Economics

Entrata

-56M

161M

Vendite

1.3B

2B

P/E

Media del settore

35.346

35.739

Rendimento da dividendi

0.8

Margine di Profitto

7.877

Dipendenti

14,147

EBITDA

314M

476M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+11.35% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.80%

3.08%

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-177M

13B

Apertura precedente

115.77

Chiusura precedente

116.2

Notizie sul Sentiment di mercato

By Acuity

48%

52%

143 / 371 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

BioMerieux Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

17 apr 2025, 08:49 UTC

I principali Market Mover

BioMerieux Shares Fall After Warning on Currency-Exchange Hit

Confronto tra pari

Modifica del prezzo

BioMerieux Previsione

Obiettivo di Prezzo

By TipRanks

11.35% in crescita

Previsioni per 12 mesi

Media 128.5 EUR  11.35%

Alto 140 EUR

Basso 120.5 EUR

Basato su 5 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per BioMerieux - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

5 ratings

2

Acquista

3

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

113.1 / 118.6Supporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Bullish Evidence

A lungo termine

Bullish Evidence

Sentiment

By Acuity

143 / 371 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo BioMerieux

bioMérieux S.A. develops and markets in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers CHROMID RANGE, a chromogen culture media; RAPIDEC CARBA NP biochemical test for the detection of carbapenemaseproducing bacteria; air, surface, and water monitoring systems; BACT/ALERT VIRTUO BACT/ALERT 3D, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction (PCR) system; BIOFIRE SPOTFIRE Lowplex PCR point-of-care system; VITEK MS, a mass spectrometry system; VITEK 2, an automated Identification and antimicrobial susceptibility testing (AST) system; API RANGE standardized ID strips; VITEK REVEAL Rapid AST system; ETEST Gradient method on culture media; BIOMERIEUX EPISEQ CS whole genome sequencing solution for epidemiologic monitoring; and VIDASB·R·A·H·M·S PCTTM, a specific marker of severe bacterial infections/sepsis. It also provides Biomérieux vision suite, a software that provides actionable information to support diagnosis and clinical decision making; culture media and associated instruments; ARGENE Monoplex PCR tests; NUCLISENS ranges, a product for automation of the molecular biology laboratory and extraction; EMAG system For DNA and RNA extraction; ESTREAM, an automated preparation station for samples to process PCR tests; GENE-UP and VERIFLOW ranges for detection of microorganisms for the food industry. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
help-icon Live chat